This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Astellas Pharma Gmbh, Medivation Prostate Therapeutics, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 424 
1 out of 12 Years Active: 2024
Title: Taoufik Ouatas: Innovator in Combination Therapy
Introduction
Taoufik Ouatas is a notable inventor based in Bizerte, Tunisia. He has made significant contributions to the field of medicine, particularly in the area of combination therapy. His innovative approach has the potential to enhance treatment options for patients.
Latest Patents
Taoufik Ouatas holds a patent for a combination therapy that provides a dosage regimen for the co-administration of enzalutamide and a strong CYP3A4 inducer. This patent represents a crucial advancement in therapeutic strategies for prostate cancer treatment.
Career Highlights
Throughout his career, Ouatas has worked with prominent companies in the pharmaceutical industry. He has been associated with Medivation Prostate Therapeutics, Inc. and Astellas Pharma GmbH, where he has contributed to the development of innovative therapies.
Collaborations
Some of his notable coworkers include Jacqueline Gibbons and Joyce Mordenti. Their collaboration has likely played a role in the success of his projects and patents.
Conclusion
Taoufik Ouatas is a distinguished inventor whose work in combination therapy showcases his commitment to improving patient care. His contributions to the pharmaceutical industry are noteworthy and reflect his innovative spirit.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile